Description:
The Market for Contract Manufacturing in In Vitro Diagnostics (IVD), 2022 provides valuable insights into the global in vitro diagnostic (IVD) industry’s contract manufacturing segment, covering market size, trends, and competitive analysis.
Report Highlights:
- Market Overview:
- Detailed examination of the multi-billion-dollar contract manufacturing segment within the IVD industry.
- Analysis of how leading worldwide producers of proprietary IVD systems are increasingly relying on outside contractors to:
- Expand existing product lines
- Broaden access to IVD testing technologies
- Increase manufacturing capacity without capital investment
- Quickly introduce tests and systems for emerging diseases (e.g., COVID-19, Monkeypox)
- Gain support for regulatory filings
- Penetrate high-growth applications, especially in point-of-care (POC) testing
- Meet specialized testing needs of major end users
- Benefits for New and Smaller IVD Producers:
- Discussion on how contract manufacturing enables new and smaller IVD producers to build up product lines and enhance competitiveness in the market.
- Exploration of the segment’s role as a major source of private label tests, instruments, and accessories sold by medical supply distributors, home healthcare outlets, and drug stores.
- Analysis of the expansion in private label applications, largely influenced by the COVID-19 pandemic.
Scope and Methodology:
- Technology Segmentation:
- In-depth analysis of contract IVD manufacturing by technology, including immunoassay, clinical chemistry, molecular assays, microbiology, hematology, histology/cytology, coagulation, blood grouping, and other technologies.
- Product Segmentation:
- Detailed segmentation by product, covering reagents and test kits, instruments and systems, and accessories.
- End-Use Applications:
- Examination of contract IVD manufacturing by end-use applications, focusing on point-of-care and clinical laboratory testing.
- Non-Manufacturing Services:
- Discussion on contract IVD services in non-manufacturing areas such as assay development, instrument design, regulatory filings, and packaging.
Market Insights:
- Principal Customers:
- Analysis of principal customers for contract IVD manufacturing and non-manufacturing services, including traditional IVD product producers, medical supply distributors, drug stores, mass merchandisers, and internet and mail-order enterprises.
- Revenue Estimates:
- Global revenue estimates for the year 2021 and forecasts for each year from 2022 to 2026, expressed in current US dollars.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: Global IVD Demand, by Product Group, 2021-2026 (million dollars)
| Product Group | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | CAGR |
| Reagents & Test Kits: | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Clinical Laboratory | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Point-of-Care | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Instruments & Systems: | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Clinical Laboratory | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Point-of-Care | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Supplies & Accessories: | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Clinical Laboratory | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Point-of-Care | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Global Total | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Clinical Laboratory | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Point-of-Care | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
Source: Kalorama Information
